Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ferrari

Showing results (501-510 of 718) with videos related to

Pageof 72
Sort By:
Leukemia|April 1, 1994
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiationS Ferrari, R Manfredini, E Tagliafico, et al.
Journal of Chemotherapy (Florence, Italy)|August 28, 1999
Cd 34+ cells and clonogenicity of peripheral blood stem cells during chemotherapy treatment in association with granulocyte colony stimulating factor in osteosarcomaM Buzzi, D Granchi, G Bacci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico RizzoliG Bacci, S Ferrari, F Bertoni, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine yearsG Bacci, S Ferrari, A Comandone, et al.
The Journal of Experimental Medicine|August 1, 1993
Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiationR Manfredini, A Grande, E Tagliafico, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapyS Ferrari, G Bacci, P Picci, et al.
Cancer|March 20, 1998
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studiesG Bacci, P Picci, S Ferrari, et al.
Acta Orthopaedica Scandinavica|May 25, 2001
Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 casesG Bacci, S Ferrari, P Ruggieri, et al.
Cancer Research|April 1, 1990
Ratios between the abundance of messenger RNA and the corresponding protein of two growth-related genes, c-myc and vimentin, in leukemia blast cellsS Ferrari, E Tagliafico, M D'Incá, et al.
The Journal of Bone and Joint Surgery. British Volume|February 12, 2002
Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapyG Bacci, S Ferrari, S Lari, et al.
Pageof 72

Showing results (501-510 of 718) with videos related to

Sort By:
Pageof 72
Leukemia|April 1, 1994
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiationS Ferrari, R Manfredini, E Tagliafico, et al.
Journal of Chemotherapy (Florence, Italy)|August 28, 1999
Cd 34+ cells and clonogenicity of peripheral blood stem cells during chemotherapy treatment in association with granulocyte colony stimulating factor in osteosarcomaM Buzzi, D Granchi, G Bacci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico RizzoliG Bacci, S Ferrari, F Bertoni, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine yearsG Bacci, S Ferrari, A Comandone, et al.
The Journal of Experimental Medicine|August 1, 1993
Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiationR Manfredini, A Grande, E Tagliafico, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapyS Ferrari, G Bacci, P Picci, et al.
Cancer|March 20, 1998
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studiesG Bacci, P Picci, S Ferrari, et al.
Acta Orthopaedica Scandinavica|May 25, 2001
Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 casesG Bacci, S Ferrari, P Ruggieri, et al.
Cancer Research|April 1, 1990
Ratios between the abundance of messenger RNA and the corresponding protein of two growth-related genes, c-myc and vimentin, in leukemia blast cellsS Ferrari, E Tagliafico, M D'Incá, et al.
The Journal of Bone and Joint Surgery. British Volume|February 12, 2002
Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapyG Bacci, S Ferrari, S Lari, et al.
Pageof 72